AgingResearch.NewsJoin free

American Diabetes Association

OrganisationROR

Trials

  • NCT07760948

    Collaborator, Phase 2, Not yet recruiting, 90 people, 12 Aug 2026

  • Integrating New Skills Into Diabetes Education With CGM

    Collaborator, Recruiting, 144 people, 11 Mar 2026

  • NCT06948825

    Collaborator, Phase 2, Recruiting, 60 people, 29 Apr 2025

  • NCT04133922

    Collaborator, Early phase 1, Withdrawn, 0 people, 21 Oct 2019

  • NCT03883412

    Collaborator, Phase 4, Recruiting, 60 people, 20 Mar 2019

  • NCT03771066

    Collaborator, Completed, 40 people, 10 Dec 2018

  • NCT03540758

    Collaborator, Phase 2, Recruiting, 100 people, 30 May 2018

  • NCT02140983

    Collaborator, Phase 1, Completed, 41 people, 16 May 2014

  • NCT02127125

    Collaborator, Phase 2, Completed, 69 people, 30 Apr 2014

  • NCT02124759

    Collaborator, Phase 2, Completed, 20 people, 28 Apr 2014

  • NCT02061969

    Collaborator, Phase 4, Completed, 140 people, 13 Feb 2014

  • NCT01950039

    Collaborator, Phase 2, Completed, 28 people, 25 Sept 2013

  • NCT01860911

    Collaborator, Phase 1, Completed, 33 people, 23 May 2013

  • NCT01808690

    Collaborator, Phase 3, Completed, 52 people, 11 Mar 2013

  • NCT01775813

    Collaborator, Phase 4, Completed, 104 people, 25 Jan 2013

  • NCT01722227

    Collaborator, Phase 3, Withdrawn, 0 people, 6 Nov 2012

  • NCT01181986

    Collaborator, Phase 4, Completed, 76 people, 16 Aug 2010

  • NCT01155518

    Collaborator, Phase 2, Terminated, 5 people, 1 Jul 2010

  • NCT01107717

    Collaborator, Phase 4, Completed, 318 people, 21 Apr 2010

  • NCT00438321

    Collaborator, Phase 1, Terminated, 66 people, 22 Feb 2007

Sources: clinicaltrials.gov

Awards made

  • Daniel S Nuyujukian

    Clinical, Cardiovascular risk factor variability and heart failure in type 2 diabetes, 1-24-PDF-57, 2024–2025, 1 Jan 2024

  • Phoenix VA Health Care System

    Clinical, Cardiovascular risk factor variability and heart failure in type 2 diabetes, 1-24-PDF-57, 2024–2025, 1 Jan 2024

  • Jeu Park

    Basic, Exercise-Driven Strategies to Inhibit Jumping Genes for Type 2 Diabetes Therapy, 11-23-PDF-05, 2023–2026, 15 Nov 2023

  • Joslin Diabetes Center

    Basic, Exercise-Driven Strategies to Inhibit Jumping Genes for Type 2 Diabetes Therapy, 11-23-PDF-05, 2023–2026, 15 Nov 2023

  • Juan Antonio Requena-Ibáñez

    Clinical, SOTA-P-CARDIA Clinical Trial., 11-23-PDF-43, 2023–2026, 15 Nov 2023

  • Icahn School of Medicine at Mount Sinai

    Clinical, SOTA-P-CARDIA Clinical Trial., 11-23-PDF-43, 2023–2026, 15 Nov 2023

  • Mount Sinai Hospital

    Clinical, SOTA-P-CARDIA Clinical Trial., 11-23-PDF-43, 2023–2026, Lead, 15 Nov 2023

  • Rachel G Miller

    Clinical, Identifying risk factor targets across different life stages to reduce complication risk in women living with type 1 diabetes, 7-23-ICTSWH-19, 2023–2026, 1 Jul 2023

  • University of Pittsburgh

    Clinical, Identifying risk factor targets across different life stages to reduce complication risk in women living with type 1 diabetes, 7-23-ICTSWH-19, 2023–2026, 1 Jul 2023

  • Abbie Smith-Ryan

    Translational, Metabolic effects of muscle and exercise across perimenopause, 7-23-ICTSWH-04, 2023–2026, 1 Jul 2023

  • University of North Carolina at Chapel Hill

    Translational, Metabolic effects of muscle and exercise across perimenopause, 7-23-ICTSWH-04, 2023–2026, 1 Jul 2023

  • Yilin Yoshida

    Translational, Early-Onset Type 2 Diabetes and Women’s Excessive Cardiovascular Risk, 7-23-JDFWH-10, 2023–2026, 1 Jul 2023

  • Tulane University

    Translational, Early-Onset Type 2 Diabetes and Women’s Excessive Cardiovascular Risk, 7-23-JDFWH-10, 2023–2026, 1 Jul 2023

  • James A Landay

    Clinical, An experiment to show culturally specific visual narrative-based behavioral smart-phone interventions lead to increased physical activity in older Latinx populations, 11-22-ICTSN-03, 2022–2025, 15 Nov 2022

  • Stanford University

    Clinical, An experiment to show culturally specific visual narrative-based behavioral smart-phone interventions lead to increased physical activity in older Latinx populations, 11-22-ICTSN-03, 2022–2025, 15 Nov 2022

  • Wanda K. Nicholson

    Effectiveness study of a lifestyle intervention versus metformin in mothers with recent gestational diabetes, 11-22-ICTSN-15, 2022–2025, 15 Nov 2022

  • George Washington University

    Effectiveness study of a lifestyle intervention versus metformin in mothers with recent gestational diabetes, 11-22-ICTSN-15, 2022–2025, 15 Nov 2022

  • Lukasz Szczerbinski

    Translational, Identifying genetic predictors of glucagon-like peptide-1 responses to a meal and their interaction with metformin., 11-22-PDFPM-03, 2022–2024, 15 Nov 2022

  • Massachusetts General Hospital

    Translational, Identifying genetic predictors of glucagon-like peptide-1 responses to a meal and their interaction with metformin., 11-22-PDFPM-03, 2022–2024, 15 Nov 2022

  • Wei Perng

    Translational, A multi-‘omics approach to identifying youth at high risk of early-onset type 2 diabetes, 7-22-ICTSPM-08, 2022–2025, 1 Jul 2022

Sources: openalex.org

Funded papers

Sources: api.crossref.org

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov

Papers